| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 3 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | African Regional Industrial Property Organization | 2 | |
| #4 | Canada | 2 | |
| #5 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Pohl Jens | 8 |
| #2 | Bechtold Rolf | 8 |
| #3 | Paulista Michael | 8 |
| #4 | Unsicker Klaus | 5 |
| #5 | Dill Othmar | 3 |
| #6 | Inagaki Mitsuko | 2 |
| #7 | Ichikawa Hideki | 2 |
| #8 | Satoh Yusuke | 1 |
| #9 | Matsumoto Tomoaki | 1 |
| #10 | Kawai Shinji | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2004132653A1 | Lyophilized composition of bone morphogenetic factor human MP52 | |
| AU1024899A | Cytokines having neurotrophic activity | |
| AU4202897A | Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons | |
| AP9701138A0 | A novel homodimer protein used in pharmaceutical preparation for treating cartlage and bone diseases. |